Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Huanzhang Hu"'
Publikováno v:
Gastroenterology Research and Practice, Vol 2022 (2022)
For those patients with hepatocellular carcinoma (HCC), it is really a heavy burden. Herein, the immune genes of HCC were analyzed in groups to determine prognostic biomarkers related to immune genes in HCC. The mRNA data, clinical data in TCGA-LIHC
Externí odkaz:
https://doaj.org/article/c86532a471ba4dc38a689679f7e61c64
Autor:
Huajun Jin, Saiqun Lv, Jiahe Yang, Xiaoning Wang, Huanzhang Hu, Changqing Su, Chengliang Zhou, Jiang Li, Yao Huang, Linfang Li, Xinyuan Liu, Mengchao Wu, Qijun Qian
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e21307 (2011)
Highly selective therapy for hepatocellular carcinoma (HCC) remains an unmet medical need. In present study, we found that the tumor suppressor microRNA, let-7 was significantly downregulated in a proportion of primary HCC tissues (12 of 33, 36.4%) a
Externí odkaz:
https://doaj.org/article/46a75293ade341908988999ae6598b14
Publikováno v:
Archives of Biochemistry and Biophysics. :109661
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::592153ced318e44f981133763114fb1d
https://doi.org/10.1016/j.abb.2023.109661
https://doi.org/10.1016/j.abb.2023.109661
Publikováno v:
Cell biochemistry and biophysics. 80(2)
Though patients with hepatocellular carcinoma (HCC) benefit from the treatment of immune checkpoint inhibitor (ICB), it is still of vital significance to develop more effective drugs and predict patients' response to ICB therapy. Herein, we utilized
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24a8b64afe2aeb7c89488dbfb153fc12
https://pubmed.ncbi.nlm.nih.gov/35195822
https://pubmed.ncbi.nlm.nih.gov/35195822
Autor:
Huaxiang Wang, Fengfeng Xu, Lingling Lu, Fang Yang, Xinghua Huang, Lizhi Lv, Huanzhang Hu, Yi Jiang
Publikováno v:
Journal of Cancer
Small nuclear ribonucleoprotein Sm D1 (SNRPD1), one of the crucial genes encoding core spliceosome components, was abnormally highly expressed in multiple types of tumors. In this study, we investigated the diagnostic and prognostic significance of S
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4355474a9eda8efcd5a79d39e12955af
https://pubmed.ncbi.nlm.nih.gov/34976182
https://pubmed.ncbi.nlm.nih.gov/34976182
Autor:
Changqing Su, Lin Fang, Yao Huang, Yan Yan, Minggao Guo, Yinghe Qiu, Yang Xu, Xuan-Dong Huang, Zhangxiao Peng, Weidan Ji, Junnian Zheng, Shuwen Shen, Huanzhang Hu
Publikováno v:
Oncotarget
The patient-derived tumor xenograft (PDTX) models can reproduce a similar natural genetic background and similar biological behaviors to tumor cells in patients, which is conducive to the assessment of personalized cancer treatment. In this study, to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::668795ecfba5034ce1d07093289a2ed2
https://doi.org/10.18632/oncotarget.2835
https://doi.org/10.18632/oncotarget.2835
Autor:
Junling Han, Dandan Wang, Huanzhang Hu, Yao Huang, Linfang Li, Jin Huajun, Lugui Qiu, Jian Liu, Qijun Qian, Meng-Chao Wu, Jing-Xin Hong
Publikováno v:
Molecular Medicine Reports. 9:1103-1111
Cirrhosis is the long‑term outcome of chronic hepatic injury and no effective therapy is currently available for this disease. Mesenchymal stromal cells (MSCs) are multipotent cells that are easily acquired and amplified, and may be potential candi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82b784238a05c88aae0c01e000278818
https://doi.org/10.3892/mmr.2014.1927
https://doi.org/10.3892/mmr.2014.1927
Autor:
Lin Jia, Yajiang Zhu, Dexin Wu, Huanzhang Hu, Huaxiang Yin, Yulin Qiu, He Qian, Min Liu, Honghao Ji, Qiuxia Xu, Zhensheng Han, Baoqing Chen
Publikováno v:
IEEE Transactions on Electron Devices. 48:1412-1420
The fabrication of sub-0.1-/spl mu/m CMOS devices and ring oscillator circuits has been successfully explored. The key technologies include: lateral local super-steep-retrograde (SSR) channel doping with heavy ion implantation, 40-nm ultrashallow sou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::455b07f994b8b3eb91a752395b591249
https://doi.org/10.1109/16.930660
https://doi.org/10.1109/16.930660
Autor:
Jiahe Yang, Huanzhang Hu, Changqing Su, Linfang Li, Qijun Qian, Meng-Chao Wu, Sai-Qun Lv, Xinyuan Liu, Xiaoning Wang, Jiang Li, Jin Huajun, Yao Huang, Chengliang Zhou
Publikováno v:
PLoS ONE, Vol 6, Iss 7, p e21307 (2011)
PLoS ONE
PLoS ONE
Highly selective therapy for hepatocellular carcinoma (HCC) remains an unmet medical need. In present study, we found that the tumor suppressor microRNA, let-7 was significantly downregulated in a proportion of primary HCC tissues (12 of 33, 36.4%) a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::62bb903fb158ae4421952f1621806f0f
http://europepmc.org/articles/PMC3140979?pdf=render
http://europepmc.org/articles/PMC3140979?pdf=render
Autor:
Shao-kun Pan, Changqing Su, Yao Huang, Xiao-cui Hu, Xiangrong Cao, Lin Fang, Ying-yan Pu, Xiaoping He, Jian-zhong Gu, Huanzhang Hu, Hong-mei Luo, Li-jun Sun
Publikováno v:
Chemico-biological interactions. 181(1)
Oncolytic adenovirus is capable of infecting, replicating in and lysing cancer cells. In adenovirus infection and replication, the wild type E1a gene (wE1a) mediates various genetic events to facilitate viral replication and exert antitumor effect. T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e5c3a7db0e7f996698c5788bb35bbe25
https://pubmed.ncbi.nlm.nih.gov/19523934
https://pubmed.ncbi.nlm.nih.gov/19523934